Overview of Dr. Tsai
Dr. Frank Tsai is an oncologist in Scottsdale, AZ and is affiliated with multiple hospitals in the area, including HonorHealth Scottsdale Shea Medical Center and HonorHealth John C. Lincoln Medical Center. He received his medical degree from Stony Brook University Health Sciences Center School of Medicine and has been in practice 15 years. Dr. Tsai accepts several types of health insurance, listed below. He is one of 47 doctors at HonorHealth John C. Lincoln Medical Center and one of 53 doctors at HonorHealth Scottsdale Shea Medical Center who specialize in Oncology. He has 6 publications and over 200 citings.
Office
10510 N 92nd Street Suite 200
Scottsdale, AZ 85258- Is this information wrong?
Education & Training
Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
Stony Brook Medicine/University HospitalResidency, Internal Medicine, 2002 - 2005
Stony Brook University Health Sciences Center School of MedicineClass of 2002
Certifications & Licensure
AZ State Medical License 2012 - 2026
CO State Medical License 2013 - 2015
NY State Medical License 2005 - 2013
Clinical Trials
- A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer Start of enrollment: 2015 Apr 29
Publications & Presentations
PubMed
- CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial.Armstrong, A., Geva, R., Chung, H., Lemech, C., Miller, W., Hansen, A., Lee, J., Tsai, F., Solomon, B., Kim, T., Rolfo, C., Giranda, V., Ren, Y., Liu, F., Kandala, B.,...> ;Investigational New Drugs. 2024 Feb 1
- 22 citationsPhase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumorsJason J. Luke, Fabrice Barlesi, Ki Y. Chung, Anthony W. Tolcher, Karen Kelly, Antoine Hollebecque, Christophe Le Tourneau, Vivek Subbiah, Frank Tsai, Steven Kao, Phili...> ;Journal for Immunotherapy of Cancer. 2021 Feb 1
- 133 citationsFirst-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting, , , , , , , , , , , , , , , , , , , > ;Journal of Nuclear Medicine. 2020 Apr 1
- Join now to see all
Press Mentions
Immersive Experiences Could Help Educate Patients, Cut down on Video Call FatigueJune 11th, 2020
First Cancer Patient Receives Dose of Super-Enhancer Inhibitor GZ17-6.02, an Advanced Cancer Drug from Genzada Pharmaceuticals, at HonorHealth Research InstituteMarch 20th, 2019
Hospital Affiliations
HonorHealth Scottsdale Shea Medical CenterScottsdale, Arizona
HonorHealth John C. Lincoln Medical CenterPhoenix, Arizona
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPOGreat West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
